Skip to main content
H.R. 2565 117th Congress House

FDA Modernization Act of 2021

Official title: To amend the Federal Food, Drug, and Cosmetic Act to allow manufacturers and sponsors of a drug to use alternative testing methods to animal testing to investi… Show full official titleShow less

Official title: To amend the Federal Food, Drug, and Cosmetic Act to allow manufacturers and sponsors of a drug to use alternative testing methods to animal testing to investigate the safety and effectiveness of a drug, and for other purposes.

Introduced: November 29, 2022 Introduced by: Vern Buchanan Republican · Florida See on congress.gov
Health Animal protection and human-animal relationshipsCell biology and embryologyComputers and information technologyDrug safety, medical device, and laboratory regulation
More subjectsShow fewer subjects
Medical researchMedical tests and diagnostic methodsResearch and development
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 16, 2021
Referred to the Subcommittee on Health.
Apr 15, 2021
Introduced in House
Apr 15, 2021
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 16, 2021

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

FDA Modernization Act of 2021

This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, sophisticated computer modeling, and other human biology-based test methods.

 Related & companion bills 1
  • HR 7667 Food and Drug Amendments of 2022
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 7

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 1st Quarter 2026 (Jan 1 - Mar 31)
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 4th Quarter 2025 (Oct 1 - Dec 31)
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 3rd Quarter 2025 (July 1 - Sep 30)
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 2nd Quarter 2025 (Apr 1 - June 30)

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 7 filings →
 Cosponsors 114
All 114 Democratic 42 Republican 36
D
Panetta, Jimmy
California · Dec 1, 2022
 D
Slotkin, Elissa
Michigan · Dec 1, 2022
 D
Carbajal, Salud O.
California · Nov 29, 2022
Manning, Kathy
· Nov 29, 2022
 D
McGovern, James P.
Massachusetts · Nov 29, 2022
 D
Tonko, Paul
New York · Nov 29, 2022
 D
Garcia, Sylvia R.
Texas · Nov 17, 2022
 D
Nadler, Jerrold
New York · Nov 17, 2022
 D
Pingree, Chellie
Maine · Nov 17, 2022
 D
Evans, Dwight
Pennsylvania · Nov 16, 2022
 D
Huffman, Jared
California · Nov 16, 2022
 R
Gosar, Paul A.
Arizona · Nov 10, 2022
 D
Golden, Jared F.
Maine · Nov 7, 2022
 R
Stefanik, Elise M.
New York · Nov 7, 2022
 R
Budd, Ted
North Carolina · Oct 21, 2022
 R
Jackson, Ronny
Texas · Oct 21, 2022
Payne, Donald
· Oct 18, 2022
Wild, Susan
· Oct 18, 2022
 D
Levin, Mike
California · Sep 30, 2022
 D
Doggett, Lloyd
Texas · Sep 28, 2022
 R
Carey, Mike
Ohio · Sep 22, 2022
 R
Fitzgerald, Scott
Wisconsin · Sep 22, 2022
Spanberger, Abigail
· Sep 22, 2022
 D
Castor, Kathy
Florida · Sep 14, 2022
Crist, Charlie
· Aug 30, 2022
 R
Bacon, Don
Nebraska · Jul 26, 2022
MALONEY, CAROLYN
· Jul 7, 2022
Phillips, Dean
· Jul 7, 2022
Lee, Barbara
· Jun 7, 2022
Bowman, Jamaal
· May 27, 2022
Trone, David
· May 27, 2022
Axne, Cynthia
· May 24, 2022
Blumenauer, Earl
· May 18, 2022
DOYLE, MIKE
· May 18, 2022
 R
McCaul, Michael T.
Texas · May 13, 2022
 D
Ross, Deborah K.
North Carolina · May 13, 2022
 R
Miller-Meeks, Mariannette
Iowa · May 10, 2022
 R
Thompson, Glenn
Pennsylvania · May 10, 2022
 R
Mast, Brian J.
Florida · Apr 27, 2022
PRICE, DAVID
· Apr 27, 2022
 D
Schakowsky, Janice D.
Illinois · Apr 27, 2022
 D
Stansbury, Melanie A.
New Mexico · Apr 27, 2022
 D
Cohen, Steve
Tennessee · Apr 18, 2022
 R
Meuser, Daniel
Pennsylvania · Apr 18, 2022
 D
Dean, Madeleine
Pennsylvania · Apr 7, 2022
Gaetz, Matt
· Apr 7, 2022
 R
Guthrie, Brett
Kentucky · Apr 7, 2022
 D
Tlaib, Rashida
Michigan · Apr 7, 2022
 D
Wasserman Schultz, Debbie
Florida · Apr 7, 2022
 D
Adams, Alma S.
North Carolina · Mar 31, 2022
Page 1 of 3 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2565: FDA Modernization Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-2565/
MLA
"H.R. 2565: FDA Modernization Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-2565/.
Bluebook (legal)
H.R. 2565, 117th Cong. (2026), https://openamerica.io/bill/117-HR-2565/.
Markdown link
[H.R. 2565: FDA Modernization Act of 2021](https://openamerica.io/bill/117-HR-2565/)
Report a problem